Tranexamic acid
- Level
- Commodity
- Parent
- 51131800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131811This classification denotes a hemostatic agent with the molecular formula C8H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6T84R30KC1, chemically known as rp 18,429 but generally known as tranexamic acid, which bears US NIH Compound Identifier 5526. European Medicines Agency schedules Tranexamic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11214MIG. The term TRANEXAMIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules tranexamic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule tranexamic acid under HS 29224995 and SITC 51465. As of Q4 2014, TRANEXAMIC ACID remains the US FDA Preferred Term for this commodity. Tranexamic acid bears US NLM identifiers UMLS ID C0040613 and NCI Concept Code C47765. SMILES: OC(=O)C1CCC(CC1)CN.
Same parent
Under 51131800 · 31Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.